Infectious Disease Diagnostics Testing Market Demonstrates Long-Term Growth Potential At 9% CAGR

The Business Research Company

The Business Research Company's Infectious Disease Diagnostics Testing Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, August 12, 2026 /EINPresswire.com/ -- "The infectious disease diagnostics testing sector has witnessed rapid expansion in recent years, driven by various health challenges and technological advancements. As the need for quick and accurate identification of infections grows, this market is set to experience continued development. Let’s explore the current market size, major growth drivers, leading regions, and key trends shaping the future of infectious disease diagnostics testing.

Market Size and Growth Outlook for Infectious Disease Diagnostics Testing
The infectious disease diagnostics testing market has shown impressive growth and is projected to rise from $42.24 billion in 2025 to $46.48 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.0%. This growth during the past years has been fueled by the increasing prevalence of infectious diseases, a surge in respiratory infection cases, expansion of diagnostic labs, heightened awareness about early diagnosis, and stronger government initiatives focused on disease control.

Looking beyond 2026, the market is expected to expand further, reaching $65.49 billion by 2030 with a CAGR of 9.0%. Factors contributing to this future growth include the rising threat of global pandemics, growing demand for rapid diagnostic technologies, increased investments in healthcare diagnostics, broader disease surveillance efforts, and a higher burden of tropical and viral diseases. Emerging market trends highlight a growing preference for rapid and early infectious disease detection, wider adoption of point-of-care testing, expanded use of molecular diagnostic techniques to identify pathogens, and enhanced large-scale screening and surveillance programs.

Download a free sample of the infectious disease diagnostics testing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15831&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Jul_PR

Understanding Infectious Disease Diagnostics Testing
Infectious disease diagnostics testing involves detecting pathogens such as bacteria, viruses, fungi, or parasites in patient samples. These tests are crucial for the accurate diagnosis of infectious diseases, enabling healthcare providers to make informed treatment decisions. Beyond individual patient care, these diagnostics play a critical role in controlling disease spread and monitoring outbreaks, making them essential tools in public health management.

Rise in Respiratory Infections as a Key Driver
One significant factor propelling the infectious disease diagnostics testing market is the increasing number of respiratory infection cases. These infections affect parts of the respiratory system including the nose, throat, airways, and lungs, and are commonly caused by viral or bacterial transmission through close contact, poor hygiene, crowded environments, and seasonal weather changes. Diagnostic testing is vital in this context, as it accurately identifies the responsible pathogens, ensuring timely and effective treatment.

For example, statistics from February 2024 by the Canadian Institute for Health Information show a 32% increase in hospital admissions due to acute upper respiratory infections—from 2,114 cases in 2022 to 2,797 in 2023. This rise underscores the growing need for infectious disease diagnostic testing to manage and treat respiratory illnesses efficiently.

View the full infectious disease diagnostics testing market report:
https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Jul_PR

Leading Regions in the Infectious Disease Diagnostics Testing Market
In 2025, North America held the largest share of the global infectious disease diagnostics testing market, reflecting its advanced healthcare infrastructure and high demand for diagnostic services. Meanwhile, the Asia-Pacific region is projected to be the fastest-growing market in the coming years, driven by increasing healthcare investments, population growth, and rising disease prevalence.
The market report covers key regions such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of the global infectious disease diagnostics testing landscape.

Our 2026 market reports now feature expanded strategic intelligence through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology and future trend analysis, along with updated graphics and tables.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company"

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X